Related Experiment Video
Updated: Jul 17, 2026
08:42
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes
Birgit Herting1, Bettina Beuthien-Baumann, Katrin Pöttrich
1Department of Neurology, Technische Universität Dresden, Germany. birgit.herting@mailbox.tu-dresden.de
Summary
Depression in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) patients is linked to reduced frontal brain metabolism. This suggests prefrontal dysfunction contributes to depressive symptoms in these neurodegenerative conditions.
Area of Science:
- Neuroscience
- Neurology
- Psychiatry
Background:
- Depressive symptoms are prevalent in neurodegenerative disorders.
- Frontal-subcortical pathway disruption is implicated in depression associated with basal ganglia diseases.
Purpose of the Study:
- To test if frontal dysfunction contributes to depression in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP).
Main Methods:
- Positron emission tomography with (18)F-fluorodeoxyglucose to measure cerebral glucose metabolism.
- Voxel-based statistical parametric mapping to compare regional metabolism between patients and controls.
- Assessment of depressive symptom severity and locomotor disability.
Main Results:
- MSA patients showed metabolic decreases in frontal, parietal, cerebellar cortex, and left putamen compared to controls.
- PSP patients exhibited hypometabolism in the frontal cortex, right thalamus, and midbrain.
- Depression severity, not functional status, correlated with dorsolateral prefrontal metabolism in both patient groups.
Conclusions:
- Findings support the hypothesis that prefrontal dysfunction is associated with depressive symptoms in MSA and PSP.
- This highlights the role of frontal lobe integrity in mood regulation in these conditions.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:14Role of Cerebellum and Prefrontal Cortex in Memory
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the cerebellum's...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...